Enter assignee name

EPO Patents = 2

Trademarks = 1

Forward Citations = 25

Loading Chart...

10 inventors (with patents filed for the assignee):

Renato T Skerlj (10 out of 28 patents)

Peter T Lansbury (10 out of 23 patents)

Elyse Marie Josee Bourque (9 out of 23 patents)

4. Andrew Charles Good (8 out of 58 patents)

5. William J Greenlee (3 out of 155 patents)

6. Jianbin Zheng (1 out of 11 patents)

7. Richard B Silverman (1 out of 107 patents)

8. Dimitri Krainc (1 out of 14 patents)

9. Elyse Marie Josée Bourque (0 patent)

10. Elyse Marie Josée Bourque (0 patent)

10 patents: Sort by Forward Citations

1. 12116369 - Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators (2024-10-15),

2. 11932645 - Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2024-03-19),

3. 11878979 - Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders (2024-01-23),

4. 11453675 - Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2022-09-27),

5. 11400095 - Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2022-08-02),

6. 11351173 - Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders (2022-06-07),

7. 11345698 - Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders (2022-05-31),

8. 11192892 - Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders (2021-12-07),

9. 11168087 - Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders (2021-11-09),

10. 11091492 - Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2021-08-17),

Bial - R&D Investments, S.A. is a prominent pharmaceutical company based in Portugal, specializing in the research, development, and commercialization of innovative medicines. With a strong focus on neuroscience, cardiovascular, and other therapeutic areas, Bial is committed to improving patient outcomes through cutting-edge research and development. The company emphasizes collaboration with academic institutions and industry partners to foster innovation and bring new treatments to market. Bial's dedication to quality and sustainability is reflected in its operations and product offerings, making it a key player in the global pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

10 Patents

#1 in Coronado (S.Romão e S.Mamede)

#18 in Portugal

#54,238 in the World

Coronado (S.Romão e S.Mamede), Portugal

Bial - R&d Investments, S.a.